STOP Persistent AF
Research payments
$457,801
Through program year 2022, $457,801 in research payments was reported against STOP Persistent AF, across 148 payments.
- Paid by (largest first)
- Medtronic Vascular, Inc.; Medtronic, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $265 | 1 |
| 2021 | Research | $5,040 | 2 |
| 2020 | Research | $119,889 | 38 |
| 2019 | Research | $332,608 | 107 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Ethan Ellis Fort Collins, CO Named on 15 payments
- Robert Sangrigoli Doylestown, PA Named on 12 payments
- Joseph Souza Asheville, NC Named on 12 payments
- Wilber Su Phoenix, AZ Named on 11 payments
- Darryl Wells Seattle, WA Named on 8 payments
- Anthony Magnano Jacksonville, FL Named on 8 payments
- Albert Lin Chicago, IL Named on 6 payments
- Christopher Fellows Seattle, WA Named on 6 payments
- Jagmeet Singh Boston, MA Named on 5 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.